| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/13/2007 | WO2005086751A3 Combinatorial interleukin-2 muteins |
| 12/13/2007 | WO2005039505A3 Compositions and methods for healthy pregnancy |
| 12/13/2007 | WO2004015390A3 Lung cancer target proteins and use thereof |
| 12/13/2007 | WO2003017923A3 Anticancer polypeptide-metal complexes and compositions, methods of making, and methods of using same |
| 12/13/2007 | WO2001083684A3 A novel polypeptide, a human zinc-finger krab kraz2-13 protein and the polynucleotide encoding the polypeptide |
| 12/13/2007 | WO2001075035A3 A novel polypeptide, human peroxydase protein 9 and the polynucleotide encoding the polypeptide |
| 12/13/2007 | US20070289029 Means and Methods for Producing a Stabilized Cell of Interest |
| 12/13/2007 | US20070287949 Transdermal System for Sustained Delivery of Polypeptides |
| 12/13/2007 | US20070287827 Expression of a nucleic acid encoding NK4 in a microbial host cell, isolation of inclusion bodies containing NK4 in denatured form, solubilization of the inclusion bodies and naturation of the denatured NK4 in the presence of GSH and GSSG at pH 7-9 in phosphate buffered solution; high purity and yield |
| 12/13/2007 | US20070287826 Production of high molecular mass lectins |
| 12/13/2007 | US20070287825 Constrained cis-diol-borate bioconjugation system |
| 12/13/2007 | US20070287671 Compositions and Methods for Promoting Myocardial and Peripheral Angiogenesis |
| 12/13/2007 | US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/13/2007 | US20070287668 Methods, kits, and antibodies for detecting parathyroid hormone |
| 12/13/2007 | US20070287665 Urotensin-II agonists and antagonists |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 12/13/2007 | US20070287660 Chimeric metalloenzyme comprising fibrin binding domain for for use in treatment and prevention of thrombosis and cardiovascular disorders |
| 12/13/2007 | US20070287629 Detecting ligand binding to the complex of the protein; for identifying and selecting a protein or protein complex with increased affinity to a ligand, relates to nucleic acid molecules encoding PMA or 14-3-3 with decreased affinity to a ligand and to methods of generating transgenic plants |
| 12/13/2007 | US20070287189 bioinformatics; use of computer database to identify zinc finger proteins to target sites such as oncogenes |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070287172 Culturing a host cell that includes a recombinant expression vector, wherein the recombinant expression vector includes a nucleic acid sequence encoding a polypeptide elicits an immune response; penumonia treatment |
| 12/13/2007 | US20070287171 Process for production of proteins as soluble proteins |
| 12/13/2007 | US20070287170 Engineered heterodimeric protein domains |
| 12/13/2007 | US20070287169 In-Gel Tagging And In-Gel Digestion For Phosphoproteins Analysis And Phosphorylation Site Identification |
| 12/13/2007 | US20070287167 Dual-Transfected Cells Lines As In Vitro Screening Tools For Pharmaceutical Compound Profiling: A Model For The Heptobiliary Elimination |
| 12/13/2007 | US20070287163 Methods for Diagnosis of Acute Myeloid Leukemia |
| 12/13/2007 | US20070287154 Canine Tas1r1, Tas1r2, and Tas1r3 receptor genes; screening for compounds that modify the genes' function or activity; modifying taste preferences, ingestive responses, or general behavior of a mammal such as a dog by administering compounds that affect the function or activity of the gene |
| 12/13/2007 | US20070287146 Method for expressing a functional membrane-bound receptor protein using budded baculovirus |
| 12/13/2007 | US20070286874 Recombinant attenuated clostridium organisms and vaccine |
| 12/13/2007 | US20070286873 Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor |
| 12/13/2007 | US20070286870 Modified Vp1-Capsid Protein Of Parvovirus B19 |
| 12/13/2007 | US20070286869 Influenza virus vaccine composition and methods of use |
| 12/13/2007 | US20070286862 Cancer Associated Antigens |
| 12/13/2007 | US20070286860 Compositions and Methods for Inducing Anti-Tumor Immunity |
| 12/13/2007 | US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard) |
| 12/13/2007 | US20070286843 Recombinant Polypeptides of the Members of the Tnf Ligand Family and Use Thereof |
| 12/13/2007 | US20070286807 Method Of Inducing Or Modulating Immune Response |
| 12/13/2007 | US20070286806 Methods and Compositions for Modulating a Steroid Receptor |
| 12/13/2007 | US20070284588 Follicle stimulating hormone supreagonists |
| 12/13/2007 | DE102006026586A1 Fluoreszierende Proteine wfCGFP, sowie deren Verwendung Fluorescent proteins wfCGFP, and their use |
| 12/13/2007 | CA2657946A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease |
| 12/13/2007 | CA2654181A1 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods |
| 12/13/2007 | CA2653966A1 Perforin-2 proteins |
| 12/13/2007 | CA2653781A1 Stabilized insulin-like growth factor polypeptides |
| 12/13/2007 | CA2653444A1 Blood-brain barrier targeting antibodies |
| 12/13/2007 | CA2652989A1 Derivatized insulin oligomers |
| 12/13/2007 | CA2628116A1 Compositions and methods for diagnosing and treating cancer |
| 12/12/2007 | EP1865320A2 Cellular antanonist |
| 12/12/2007 | EP1865316A1 Screening methods for compounds that modulate the activity of G-protein coupled receptors |
| 12/12/2007 | EP1865066A2 Genetic immunisation against cervical carcinoma |
| 12/12/2007 | EP1865065A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/12/2007 | EP1865064A1 A method of expressing small peptides using cereal non-storage proteins as fusion carrier in endosperm and the use thereof |
| 12/12/2007 | EP1865062A2 Altered OspA of Borrelia burgdorferi |
| 12/12/2007 | EP1865061A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 12/12/2007 | EP1865060A1 Transcriptional Intermediary Factor-2 |
| 12/12/2007 | EP1865059A1 A novel protein, a gene encoding therefor and a method of using the same |
| 12/12/2007 | EP1865001A1 Specific protease inhibitors and their use in cancer therapy |
| 12/12/2007 | EP1864997A1 ROR ALPHA PROMOTING THE INDUCTION OF Bmal1 EXPRESSION |
| 12/12/2007 | EP1864996A1 Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker. |
| 12/12/2007 | EP1864691A1 Modified CEA nucleic acid and expression vectors |
| 12/12/2007 | EP1864681A1 Growth factor modified protein matrices for tissue engineering |
| 12/12/2007 | EP1864678A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene |
| 12/12/2007 | EP1864676A1 Antigenic modification of polypeptides |
| 12/12/2007 | EP1864675A1 Orally administered peptides to ameliorate atherosclerosis |
| 12/12/2007 | EP1864135A1 A peptide fingerprint from the de radation of elastin by hne |
| 12/12/2007 | EP1864125A2 Vgf peptide fragments as biomarkers for schizophrenic and bipolar disorders |
| 12/12/2007 | EP1863920A1 Method for improved isolation of recombinantly produced proteins |
| 12/12/2007 | EP1863914A1 Tuberculosis vaccine and method for making same |
| 12/12/2007 | EP1863850A1 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
| 12/12/2007 | EP1863843A2 Method for cleaning marine collagen and the treatment thereof to form porous sponges |
| 12/12/2007 | EP1863842A2 High affinity hiv t cell receptors |
| 12/12/2007 | EP1863841A1 Compounds for use in the treatment of obesity |
| 12/12/2007 | EP1863840A1 Pegylated single-chain insulin |
| 12/12/2007 | EP1863839A2 Acylated glp-1 compounds |
| 12/12/2007 | EP1863838A1 Statherin peptide and use in medicine |
| 12/12/2007 | EP1863837A1 Synthetic zinc finger peptide ligature for forming binding proteins configured in series for addressing specific regions of double-stranded dna (zinc finger probes) |
| 12/12/2007 | EP1863836A2 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 12/12/2007 | EP1863835A2 Vaccine and antibodies against parasitic nematodes |
| 12/12/2007 | EP1863834A1 Polypeptides and nucleic acids encoding same |
| 12/12/2007 | EP1863830A2 Affinity purification of protein |
| 12/12/2007 | EP1863829A2 Method for protein purification comprising heat incubation in acetic acidic solution |
| 12/12/2007 | EP1863537A2 Dimeric peptide agonists of the glp-1 receptor |
| 12/12/2007 | EP1863531A1 Improvements in or relating to treatment and prevention of viral infections |
| 12/12/2007 | EP1863527A2 Mannose immunogens for hiv-1 |
| 12/12/2007 | EP1863525A2 Polypeptides |
| 12/12/2007 | EP1863521A1 Extended glp-1 compounds |
| 12/12/2007 | EP1863340A2 Gene disruptions, compositions and methods relating thereto |
| 12/12/2007 | EP1766005A4 Promotion of somatic embryogenesis in plants by pga37 gene expression |
| 12/12/2007 | EP1743034B1 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof |
| 12/12/2007 | EP1735335A4 Cell-killing peptide |
| 12/12/2007 | EP1639089A4 Transcription factor |
| 12/12/2007 | EP1613648B1 Purification of peptides from colostrum |
| 12/12/2007 | EP1532250B1 Fcyriia transgenic animal model for autoimmune disease |
| 12/12/2007 | EP1490492B1 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 12/12/2007 | EP1470236B1 Methods and compositions for protein expression and purification |
| 12/12/2007 | EP1432803B1 Fragments of the human zn-alpha2-glycoprotein and their use in methods of treatment of obesity |
| 12/12/2007 | EP1355668B1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 12/12/2007 | EP1349869A4 Method of identifying antibacterial compounds |
| 12/12/2007 | EP1309618B1 Leucine-based motif and clostridial neurotoxins |
| 12/12/2007 | EP1237912B1 Five-helix protein |